Pharmacological profile of the selective mitochondrial F1F 0 ATP hydrolase inhibitor BMS-199264 in myocardial ischemia

Cardiovascular Therapeutics

Volumn 26, Issue 4, 2008, Pages 287-296

  Grover, Gary J ^a,b   Malm, Johan ^a  

^a Eurofins PSL ^*  (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE HYDROLASE INHIBITOR; AUROVERTIN B; BMS 199264; BMS 250685; HYDROLASE INHIBITOR; MITOCHONDRIAL PROTEIN; OLIGOMYCIN; PROTEIN IF 1; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; UNCLASSIFIED DRUG;

DRUG SELECTIVITY; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; AUROVERTINS; ENZYME INHIBITORS; IMIDAZOLES; MITOCHONDRIA; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; MYOCARDIAL ISCHEMIA; OLIGOMYCINS; PROKARYOTIC INITIATION FACTOR-1; PROTON-TRANSLOCATING ATPASES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 55849150985     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2008.00065.x     Document Type: Review

References (53)

1. Kedem J, Grover GJ, Weiss HR. Nitroglycerin improves regional oxygenation of partially occluded canine myocardium. J Cardiovasc Pharmacol 1985 7 : 760 766.
2. Hoffman BB, Lefkowitz RJ. Adrenergic receptor antagonists. In : Goodman Gilman A, Rall TW, Nies AS, Taylor P, editors. The pharmacological basis of therapeutics, 8th ed, 1990 221 243.
3. Triggle DJ. Calcium antagonists. In Antonaccio M, editor. Cardiovascular pharmacology, 3rd ed. 1990 107 160.
4. Murry CE, Richard VJ, Reimer KA. Ischemic preconditioning slow energy metabolism and delays ultrastructrual damage during sustained ischemia. Circ Res 1990 66 : 913 931.
5. Grover GJ, Sleph PG. The dissociation of cardiodepression and cardioprotection with calcium antagonists: Diltiazem protects ischemic rat myocardium with a lower functional cost than nifedipine and verapamil. J Cardiovasc Pharmacol 1989 14 : 331 340.
6. Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RD, D'Alonzo AJ, Lodge NJ, Smith MA, Grover GJ. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive potassium channels: Possible mechanism of cardioprotection. Circ Res 1997 81 : 1072 1082.
7. Grover GJ, Newburger Sleph PJ, Dzwonzcyk S, Taylor S, Ahmed S, Atwal K. Cardioprotective effects of the potassium channel opener cromakalim: Stereoselectivity and effects on myocardial adenine nucleotides. J Pharmacol Exp Ther 1991 257 : 156 162.
8. + channels involves high-energy phosphate preservation. Am J Physiol 1993 265 : H1809 H1818.
9. Jennings RB, Reimer KA, Steenbergen C. Effect of inhibition of the mitochondrial ATPase on net myocardial ATP in total ischemia. J Mol Cell Cardiol 1991 23 : 1383 1395.
10. Rouslin W, Broge CW, Gruppe IL. ATP depletion and mitochondrial functional loss during ischemia in slow and fast heart rate hearts. Am J Physiol 1990 259 : H1759 H1759.
11. 0-ATPase: Effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activity. Am J Physiol Heart Circ Physiol 2004 287 : H1747 H1755.
12. 0 ATPase. Circulation 1995 91 : 2810 2818.
13. Mitchell P. Vectorial chemistry and the molecular mechanics of chemiosmotic coupling: Power transmission by proticity. Trans Biochem Soc 1976 4 : 399 405.
14. 0 complex. Ann Rev Microbiol 1966 50 : 791 824.
15. + transport to rotary catalysis in F-type ATP synthases: Structure and organization of the transmembrane rotary motor. J Exp Biol 2000 203 : 9 17.
16. 0 ATP synthase. Biochim Biophys Acta 1998 1365 : 135 142.
17. Uhlin U, Cox GB, Guss JM. Crystal structure of the epsilon subunit of the proton-translocating ATP synthase from Escherichia coli. Structure 1997 5 : 1219 1230.
18. 1 ATP synthase. J Biol Chem 1990 74 : 15598 15604.
19. 1-ATPase from bovine heart mitochondria. Nature 1994 70 : 621 628.
20. 0 complex of the ATP synthase from Escherichia coli. J Exp Biol 2000 203 : 19 28.
21. 0 ATP synthase. Biochemistry 1998 37 : 8817 8824.
22. 1-ATPase in reconstituted membranes using atomic force microscopy. FEBS Lett 1996 392 : 110 113.
23. Capaldi R, Schulenberg J, Murray J, Aggeler R. Cross-linking and electron microscopy studies of the structure and functioning of the Escherichia coli ATP synthase. J Exp Biol 2000 203 : 29 33.
24. 0 complex of the Escherichia coli ATP synthase: Investigation by electron spectroscopic imaging and immunoelectron microscopy. Eur Biochem 1995 230 : 58 67.
25. 0 type ATPase. J Biol Chem 1996 271 : 13888 13891.
26. 2+ is bound. J Biol Chem 1993 268 : 20831 20837.
27. 1 ATPase. Modification of these sites with tetrafluorophenlyazide-maleimides and examination of changes in the binding of the epsilon subunit when different nucleotides are in catalytic sites. Biochemistry 1992 31 : 2956 2961.
28. 0 ATP synthase. Biochim Biophys Acta 1998 1365 : 135 142.
29. 1 ATPase. J Biol Chem 1995 270 : 9185 9191.
30. 0 ATP synthase. J Biol Chem 1998 273 : 17178 17185.
31. 1 ATPase synthase. J Biol Chem 1998 273 : 31765 31769.
32. 0F1 during ATP synthesis detected by single-molecule spectroscopy. Biochim Biophys Acta 2006 1757 : 311 319.
33. 1-ATPase. Nature 1997 386 : 299 302.
34. 1-ATPase is a highly efficient molecular motor that rotates with discrete 120° steps. Cell 1998 931117 931124.
35. 0 ATP synthases. J Exp Biol 2000 203 : 51 59.
36. 1-ATP synthase. Curr Protein Pept Sci 2000 3 : 451 460.
37. 1 adenosine triphosphatase. J Biol Chem 1982 257 : 12030 12038.
38. Cross RL, Cunningham D, Tamura JK. Binding change mechanism for ATP synthesis by oxidative phosphorylation and photophosphorylation. Curr Top Cell Regulat 1984 24 : 335 344.
39. Cross RL, Grubmeyer C, Penefsky HS. Mechanism of beef heart mitochondria, rate enhancements resulting from cooperative interactions from multiple sites. J Biol Chem 1982 257 : 12101 12105.
40. 0 ATPase: Is ATP synthase a reversible molecular machine. J Exp Biol 2000 203 : 41 49.
41. Pullman ME, Monroy GC. A naturally occurring inhibitor of mitochondrial adenosine triphosphatase. J Biol Chem 1963 238 : 3762 3769.
42. 0 ATPase. Biochim Biophys Acta 2000 1458 : 343 355.
43. 1-inhibitor protein complex carries out uni- and multisite ATP hydrolysis. J Biol Chem 1990 265 : 19002 19006.
44. Horstman LL, Racker EJ. Partial resolution of the enzyme catalyzing oxidative phosphorylation. XXII. Interaction between adenosine triphosphatase inhibitor and adenosine triphosphatase. J Biol Chem 1970 245 : 1336 1344.
45. 1 beta subunit. FEBS Lett 1988 229 : 224 228.
46. Minauro-Sanmiguel F, Bravo C, Garcia J. Cross-linking of the endogenous inhibitor protein (IF1) with rotor (gamma, epsilon) and stator (alpha) subunits of the ATP synthase. Bioenerg Biomembr 2002 34 : 433 443.
47. Rouslin W. The mitochondrial adenosine 5′-triphosphatase in slow and fast heart rate species. Am J Physiol 1987 252 : H622 H627.
48. Rouslin W, Broge CW. Regulation of the mitochondrial adenosine 5′-triphosphatase in situ during ischemia and in vitro in intact and sonicated mitochondria from slow and fast heart rate species. Arch Biochem Biophys 1990 280 : 103 111.
49. 1 content, and proton conductivity of ESMP from control and ischemic slow and fast heart rate hearts. J Bioenerg Biomembr 1995 27 : 459 466.
50. 0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-aryl)-imidazole substituted benzopyran derivatives as selective hydrolase inhibitors. J Med Chem 2004 47 : 1081 1084.
51. Van der Heide RS, Hill ML, Reimer KA, Jennings RB. Effect of reversible ischemia on the activity of the mitochondrial ATPase: Relationship to ischemic preconditioning. J Mol Cell Cardiol 1995 28 : 103 112.
52. 0 ATPase inhibition. Am J Physiol Heart Circ Physiol 1998 43 : H90 H97.
53. 0 ATP hydrolase. Bioorg Med Chem Lett 2004 14 : 1031 1034.